FDA rejects Mylan ’s generic Advair again

Mylan announced that the FDA will not approve its Abbreviated New Drug Application for the generic version of GlaxoSmithKline ' s asthma drug, Advair Diskus, due to “minor deficiencies” in the application.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news